Ozgene is an Australian company that provides contract research services for global markets. Ozgene custom designs and generates genetically modified (GM) mice, which are currently the only animal models allowing researchers to precisely mimic human conditions of genetic disorders on a molecular level. GM mice represent the most sophisticated and valuable tools in functional genomics and drug target validation.
Ozgene prides itself as a company managed by 'Scientists for Scientists'. The company was founded by two scientists, Dr Frank Koentgen and Dr Gabi Suess, in November 1999. Dr Koentgen has 20 years of international experience in the management and production of GM mice. Drs Koentgen and Suess were the first to produce and publish C57BL/6 knockout mice in 1993. Their work has been published in scientific journals such as Cell, Nature, Science, Immunity, PNAS and Nature Medicine.
Ozgene exports 80% of its services. Ozgene’s global customer base includes individual academics, research institutes, biotechnology companies and multinational pharmaceutical companies from North & South America, Europe, Asia, Australia, and New Zealand. In several cases Ozgene is either the preferred supplier or the sole supplier of knockout, knockin and transgenic mouse models.